Ven Bio Partners LLC Portfolio Holdings

Ven Bio Partners LLC

  • $122 Million
  • Q3 2024

Ven Bio Partners LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $122 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pharvaris N.V. with a value of $79.4M, Harmony Biosciences Holdings, Inc. with a value of $24.6M, Alx Oncology Holdings Inc with a value of $17.7M, Acelyrin Inc with a value of $0, and Alumis Inc with a value of $0.

Examining the 13F form we can see an decrease of $55.3M in the current position value, from $177M to 122M.

Ven Bio Partners LLC is based out at San Francisco, CA

Below you can find more details about Ven Bio Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $122 Million
Healthcare: $122 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$62.8M
$17.7 Million 14.51% of portfolio
9,699,925
Q3 2020 New

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $122 Million
  • Prior Value $177 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Ven Bio Partners LLC Portfolio

Follow Ven Bio Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ven Bio Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email